biogen idec

Jefferies & Company has raised the price target on Biogen Idec (NASDAQ: BIIB) from $87 to $100 and maintains its Buy rating.

Piper Jaffray has raised the price target on Biogen Idec (NASDAQ: BIIB) from $70 to $82 and maintains its Neutral rating.

Piper Jaffray is out with its report today on Biogen Idec (NASDAQ: BIIB), maintaining Neutral. In a note to clients, Piper Jaffray writes, "We remain Neutral on BIIB shares, as we expect use of JCV assay and PML concerns related to long term Tysabri use to lead to patients increasingly going on...

Best 1) Cubist Pharmaceuticals (NASDAQ: CBST): Wedbush analysts upgraded the stock of this company to outperform from neutral. Shares are currently up 14.85% to $29.05. 2) Questcor Pharmaceuticals (NASDAQ: QCOR): The company released preliminary operating metrics for its March quarter after the...

Biogen Idec, Inc. (NASDAQ: BIIB) non GAAP EPS for 3Q10 was $1.35 vs. consensus at $1.23. Top line beat was aided by solid Avonex figures (usually weak in 3Q), with WW sales at $644M vs. consensus at $621. “The Avonex beat was aided by favorable increases in inventories, hedging gains ($17M) and a...

Jefferies believes that the Street is too pessimistic on Biogen Idec (NASDAQ: BIIB) franchises due to recently launched competition. In its report, Jefferies writes "Based on data and physician feedback at ECTRIMS, we are revising our estimates for BIIB. We have altered our ratio of JCV positive vs...

Goldman Sachs has published a research report for Baxter International Inc. (NYSE: BAX). In the report, Goldman writes "We attended Biogen Idec's Hemophilia R&D Roundtable in Cambridge, MA, to get an update on the Hemophilia market as well as new recombinant technologies. We came away...

Citigroup has published a research report for Biogen Idec Inc. (NASDAQ: BIIB). In the report, Citigroup writes "[Today] BIIB hosted a hemophilia day. Hemophilia is a multi-billion dollar market where BIIB is developing 2 differentiated long acting coagulation products. Overall, little new...